Sean Lee
Stock Analyst at HC Wainwright & Co.
(0.98)
# 2,798
Out of 4,479 analysts
67
Total ratings
26.67%
Success rate
-17.96%
Average return
Main Sectors:
Top Industries:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VSTM Verastem | Reiterates: Buy | $18 | $2.94 | +496.25% | 9 | May 28, 2024 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $12 → $6 | $5.41 | +10.91% | 7 | May 15, 2024 | |
| GRTS Gritstone bio | Maintains: Buy | $7 → $4 | $0.57 | +598.08% | 9 | May 13, 2024 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $2 | $0.72 | +177.78% | 6 | May 10, 2024 | |
| MYO Myomo | Reiterates: Buy | $6.5 | $2.81 | +131.32% | 2 | May 9, 2024 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.82 | +21.68% | 9 | May 7, 2024 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $9.90 | +102.02% | 7 | Mar 4, 2024 | |
| THMO ThermoGenesis Holdings | Reiterates: Buy | $5 | $0.16 | +3,025.00% | 6 | Nov 14, 2023 | |
| PSTV Plus Therapeutics | Reiterates: Buy | $8 | $1.55 | +416.13% | 7 | Aug 15, 2023 | |
| KZIA Kazia Therapeutics | Upgrades: Buy | $2 | $0.21 | +833.27% | 2 | Apr 11, 2023 | |
| AKTX Akari Therapeutics, | Initiates: Buy | $30 | $3.10 | +867.74% | 1 | Dec 5, 2022 | |
| VIRI Virios Therapeutics | Downgrades: Neutral | n/a | $0.23 | - | 2 | Sep 20, 2022 |
Verastem
May 28, 2024
Reiterates: Buy
Price Target: $18
Current: $2.94
Upside: +496.25%
CASI Pharmaceuticals
May 15, 2024
Maintains: Buy
Price Target: $12 → $6
Current: $5.41
Upside: +10.91%
Gritstone bio
May 13, 2024
Maintains: Buy
Price Target: $7 → $4
Current: $0.57
Upside: +598.08%
Monopar Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $2
Current: $0.72
Upside: +177.78%
Myomo
May 9, 2024
Reiterates: Buy
Price Target: $6.5
Current: $2.81
Upside: +131.32%
Cytosorbents
May 7, 2024
Reiterates: Neutral
Price Target: $1
Current: $0.82
Upside: +21.68%
Alphatec Holdings
Mar 4, 2024
Reiterates: Buy
Price Target: $20
Current: $9.90
Upside: +102.02%
ThermoGenesis Holdings
Nov 14, 2023
Reiterates: Buy
Price Target: $5
Current: $0.16
Upside: +3,025.00%
Plus Therapeutics
Aug 15, 2023
Reiterates: Buy
Price Target: $8
Current: $1.55
Upside: +416.13%
Kazia Therapeutics
Apr 11, 2023
Upgrades: Buy
Price Target: $2
Current: $0.21
Upside: +833.27%
Akari Therapeutics,
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $3.10
Upside: +867.74%
Virios Therapeutics
Sep 20, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.23
Upside: -